Prevention of cyclosporine-induced nephrotoxicity with dietary glycine

Transplantation

Volumn 63, Issue 11, 1997, Pages 1661-1667

  Thurman, Ronald G ^a   Zhong, Zhi ^a   Von Frankenberg, Moritz ^a   Stachlewitz, Robert F ^a   Bunzendahl, Hartwig ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; GLYCINE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DOSE RESPONSE; DRUG MIXTURE; GLOMERULUS FILTRATION RATE; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY NECROSIS; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMAL FEED; ANIMALS; CYCLOSPORINE; DIET; EATING; GLYCINE; KIDNEY; KIDNEY DISEASES; LEUKOCYTES; MACROPHAGES; MALE; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN;

EID: 0030941332     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199706150-00021     Document Type: Article

References (38)

1. Wood AJ, Mauer G, Niederberger W, Beveridge T. Cyclosporine: pharmacokinetics, metabolism, and drug interactions. Transplant Proc 1983; 15: 2409.
2. McCauley J, Takaya S, Fung J, et al. The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc 1991; 23: 1444.
3. Christians U, Sewing K-F. Cyclosporin metabolism in transplant patients. Pharmacol Ther 1993; 57: 291.
4. Berg KJ, Forre O, Bjerkhoel F, et al. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney Int 1986; 29: 1180.
5. Young BA, Burdmann EA, Johnson RJ, et al. Cellular proliferation and macrophage influx precedes interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1995; 48: 439.
6. Wilson PD, Schrier RW. Nephron segment and calcium as determinants of anoxic cell death in renal cultures. Kidney Int 1986; 29: 1172.
7. Murray BM, Paller MS, Ferris TF. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985; 28: 767.
8. Larochelle P. Renal tubular effects of calcium antagonists. Kidney Int 1992; 41: S-49.
9. Sorensen SS, Skovbon H, Eiskjaer H, Thomsen K, Pedersen EB. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporine-treated renal transplant recipients. Nephrol Dial Transplant 1992; 7: 69.
10. Venkatachalam MA, Weinberg JM. Mechanisms of cell injury in ATP-depleted proximal tubules: role of glycine, calcium, and polyphosphoinositides. Nephrol Dial Transplant 1994; 9: 15.
11. Garza-Quintero R, Weinberg JM, Ortega-Lopez J, Davis JA, Venkatachalam MA. Conservation of structure in ATP-depleted proximal tubules: role of calcium, polyphosphoinositides, and glycine. Am J Physiol 1993; 265: F605.
12. Zhong Z, Jones S, Thurman RG. Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Physiol 1996; 270: G332.
13. 2+ in Kupffer cells by endotoxin (LPS) via actions on a chloride channel. Hepatology 1995; 22: 803.
14. Stachlewitz RF, Ikejima K, Thurman RG. Increases in intracellular calcium in neutrophils (PMNs) due to formyl-methionineleucine-phenylalanine (FMLP) and endotoxin are blocked completely by glycine [Abstract]. Hepatology 1995; 22: 1105.
15. English J, Evan A, Houghton DC, Bennett WM. Cyclosporine-induced acute renal dysfunction in the rat. Transplantation 1987; 44: 135.
16. Jackson NM, Hsu C-H, Visscher GE, Venkatachalam MA, Humes HD. Alterations in renal structure and function in a rat model of cyclosporine nephrotoxicity. J Pharm Exp Ther 1987; 242: 749.
17. Wolf A, Clemann N, Frieauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporin A-mediated impairment of renal functions. Transplant Proc 1994; 26: 2902.
18. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity: attenuation by an antioxidant-inhibitor of lipid peroxidation in vitro and in vivo. Transplantation 1994; 58: 940.
19. Thurman RG, Zhong Z, Frankenberg MV. Cyclosporin-induced nephrotoxicity, a common side effect after liver transplantation, is prevented with dietary glycine [Abstract]. Hepatology 1996; 24: 1230.
20. Laiken ND, Fanestil DD. Filtration and blood flow. In: West JB, ed. Physiological basis of medical practice. Baltimore: Williams & Wilkins, 1985: 461.
21. Farthing MJG, Clark ML. Nature of the toxicity of cyclosporin A in the rat. Biochem Pharmacol 1981; 24: 3311.
22. Rose ML, Bojes HK, Arteel GE, et al. A diet containing glycine inhibits the mitogenic effect of the non-genotoxic carcinogen WY-14,643: role of Kupffer cells. In: Wisse E, Knook DL, Balabaud C, eds. Cells of the hepatic sinusoid. Leiden, The Netherlands: The Kupffer Cell Foundation (in press).
23. Thomson AW, Whiting PH, Simpson JG. Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions 1984; 15: 306.
24. Rogers TS, Elzinga L, Bennett WM, Kelley VE. Selective enhancement of thromboxane in macrophages and kidneys in cyclosporine-induced nephrotoxicity. Transplantation 1988; 45: 153.
25. Kon V, Sugiura M, Inagami T, Harvie Br, Ichikawa I, Hoover RL. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990; 37: 1487.
26. Baud L, Ardaillou R. Tumor necrosis factor in renal injury. Miner Electrolyte Metab 1995; 21: 336.
27. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest 1986; 55: 455.
28. Schilling M, den Butter G, Marsh DC, Beizer FO, Southard JH. Glycine inhibits phospholipolysis of hypoxic membranes. Tex Med 1994; 6: 140.
29. Xue H, Bukoski RD, McCarron DA, Bennett WM. Induction of contraction in isolated rat aorta by cyclosporine. Transplantation 1987; 43: 715.
30. Moss NG, Powell SL, Falk RJ. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 1985; 82: 8222.
31. Stein RD, Weaver LC, Yardley CP. Ventrolateral medullary neurones: effects on magnitude and rhythm of discharge of mesenteric and renal nerves in cats. J Physiol 1989; 408: 571.
32. Weinberg JM, Davis JA, Roeser NF, Venkatachalam MA. Role of intracellular pH during cytoprotection of proximal tubule cells by glycine or acidosis. J Am Soc Nephrol 1994; 5: 1314.
33. Venkatachalam MA, Weinberg JM, Patel Y, Saikumar P, Dong Z. Cytoprotection of kidney epithelial cells by compounds that target amino acid chloride channels. Kidney Int 1996; 49: 449.
34. Liang D, Thurman RG. Protective effects of the calcium antagonists diltiazem and TA3090 against hepatic injury due to hypoxia. Biochem Pharmacol 1992; 44: 2207.
35. Mandel LJ, Takano T, Soltoff SP, Jacobs WR, LeFurgey A, Ingram P. Multiple roles of calcium in anoxic-induced injury in renal proximal tubules. Soc Gen Physiol Ser 1987; 42: 277.
36. Miller GW, Schnellmann RG. Cytoprotection by inhibition of chloride channels: the mechanism of action of glycine and strychnine. Life Sci 1993; 53: 1211.
37. Rosse RB, Theut SK, Banay-Schwartz M, et al. Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study. Clin Neuropharmacol 1989; 12: 416.
38. Vander AJ, Sherman JH, Luciano DS. The kidneys and regulation of water and inorganic ions. In: Vander AJ, Sherman JH, Luciano DS, eds. Human physiology. New York: McGraw-Hill Publishing Company, 1990: 471.